TAURINE

Product Information

Drug: Taurine (amino sulfonic acid)

Concentration: 50 mg/mL

Vial size: 10 mL (total = 500 mg taurine)

Route: IV infusion (diluted; not for undiluted IV push)

Dosage Ranges

• Standard dose: 250–500 mg IV (≈5–10 mL of 50 mg/mL solution)
• High dose: up to 1000 mg IV (20 mL, if concentrated stock available or compounded)
• Dilution: Add to 250–500 mL carrier fluid (0.9% NaCl, Hartmann's, or CSL)
• Infusion time: 30–60 minutes
• Frequency: weekly to fortnightly

Clinical / Wellness Benefits

• Cardiac support: regulates calcium flow, helps stabilise heart rhythm
• Neurological health: calming effect on the nervous system; GABA-like action
• Antioxidant: reduces oxidative stress, supports mitochondrial health
• Exercise & recovery: reduces muscle fatigue, supports hydration/electrolyte balance
• Metabolic support: may improve insulin sensitivity and lipid metabolism
• Synergy: often combined with magnesium, B-complex, and glutathione

Safety & Precautions

• Well tolerated when infused slowly in diluted form
• Avoid rapid push → may cause hypotension, dizziness, flushing
• Use caution in renal impairment (amino acid clearance may be reduced)
• Baseline renal & hepatic function recommended if repeated use
• No known major drug interactions at wellness doses

Australian Injectable Drugs Handbook

Taurine

No data on Taurine on AIDH